Novo and UNICEF expand partnership to support a healthier start for more than 80 million children
Novo Nordisk (NVO) and UNICEF will expand their global partnership with a four-year childhood overweight and obesity prevention programme from 2027 to 2030, aiming to support a healthier start for more than 80 million children in seven countries.
Rhea-AI Summary
Novo Nordisk (NVO) and UNICEF will expand their global partnership with a four-year childhood overweight and obesity prevention programme from 2027 to 2030, aiming to support a healthier start for more than 80 million children in seven countries.
Novo Nordisk will commit USD 18 million from 2026 to 2030, with funding beginning in 2026 to support programme inception and preparation. The programme will focus on policy and community action in Mexico, Colombia, Indonesia, the Philippines, India, Egypt and Kenya, where most affected children live in low- and middle-income settings.
Interventions include growth monitoring, nutrition and physical activity counselling, peer and family support, community- and facility-based prevention, youth advocacy, basic mental health screening and support, and legislation to promote healthier diets. Delivery will be country-led and anchored in UNICEF’s Centres of Excellence model.
Positive
- None.
Negative
- None.
Details
Market Reaction – NVO
Following this news, NVO has declined 0.80%, reflecting a mild negative market reaction. Our momentum scanner has triggered 2 alerts so far, indicating moderate trading interest and price volatility. The stock is currently trading at $39.48. Trading volume is exceptionally heavy at 5.8x the average, suggesting significant selling pressure.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
- Children targeted
- more than 80 million children
- Four-year partnership expansion across seven countries
- Novo commitment
- USD 18 million
- Committed from 2026 to 2030
- Priority countries
- seven countries
- Mexico, Colombia, Indonesia, the Philippines, India, Egypt and Kenya
- Programme period
- 2027 to 2030
- Programme operations; funding begins in 2026
Key Terms
non-communicable diseases medical
type 2 diabetes medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
- The four-year expansion will focus on childhood overweight and obesity prevention for over 80 million children across seven priority countries: Mexico, Colombia, Indonesia, the Philippines, India, Egypt and Kenya
- Novo will commit USD 18 million from 2026 to 2030. The four-year programme will run from 2027 to 2030, while funding begins in 2026 to support programme inception and preparation
- Childhood obesity has surpassed underweight globally for the first time on record. One in five children and adolescents aged 5 to 19 is now living with overweight, including obesity¹
Bagsværd, Denmark / New York, United States, 22 September 2026 – Novo Nordisk and UNICEF today announced a four-year expansion of their global partnership to help prevent childhood overweight and obesity, aiming to support a healthier start in life for more than 80 million children. Novo is committing USD 18 million from 2026 to 2030 to advance evidence-based policies and prevention services in seven priority countries. The expansion arrives at a turning point in global child health: childhood obesity has now surpassed underweight globally for the first time on record, according to UNICEF’s 2025 Child Nutrition Report.¹
From 2026 to 2030, the partnership will support governments to create environments that ensure healthier options are more accessible to children and families— from the food that is offered and promoted to children, to the schools, cities and health services they rely on every day.
“It is concerning that childhood obesity has surpassed underweight, affecting 1 in 10 school-aged children and adolescents globally,” said Kitty van der Heijden, Deputy Executive Director, Partnerships, UNICEF. “The moment to act is now. Through our partnership with Novo, UNICEF will work with governments to turn evidence into policies, build services, and create environments that protect children early, so every child has a fair chance to eat well, move, feel supported and grow up healthy.”
“Preventing childhood obesity requires long-term, collective action to create healthier environments for children,” said Elin Jäger, SVP, chief of staff and head of CEO Office, Corporate Strategy and Sustainability, Novo. “Through our continued partnership with UNICEF, we want to support proven prevention approaches that can become part of the systems children rely on every day, helping create healthier environments for more than 80 million children.”
Building on joint progress since 2019
Since 2019, Novo and UNICEF have helped raise childhood overweight and obesity from an under-recognised issue to a growing global policy and public health priority. Building on this foundation, the next phase of the partnership will deepen efforts in existing countries and expand to new contexts, combining evidence-based policy advocacy, technical assistance, youth-led advocacy and peer support, and social and behaviour change communication.
Scope of the expanded programme
The expanded programme will support action in Mexico, Colombia, Indonesia, the Philippines, India, Egypt and Kenya, while accelerating learning across regions.
Interventions will include:
- Growth monitoring
- Nutrition and physical activity counselling
- Peer and family support
- Community- and facility-based prevention activities
- Youth advocacy
- Basic mental health screening and support
- Legislation to promote better diets and healthy food
Success will be measured by the number of children reached by evidence-based prevention policies and interventions. Progress and challenges will be reported transparently.
The scale of the challenge
Childhood overweight and obesity now affect around 35 million children under 5 and more than 391 million children and adolescents aged 5 to 19, with 81 per cent of them living in low- and middle-income countries.¹ The impacts can be immediate and lifelong, increasing the risk of early-onset type 2 diabetes and other non-communicable diseases, while also affecting children’s wellbeing through stigma and discrimination.
Delivery will be country-led and anchored in UNICEF’s Centres of Excellence model, led from Nairobi with satellite support in Bangkok and Panama.
For further information on the partnership and programme progress, visit novonordisk.com/sustainable-business and unicef.org
UNICEF does not endorse any company, brand, organisation, product or service.
Novo is the global healthcare company that believes lasting health starts now. For over a century, we’ve combined leading scientific expertise with a deep understanding of people’s lives. We develop treatments and support that help millions of people make progress they can see, feel and sustain now and in the future. Every day, over 67,000 employees around the world advance our purpose to drive change for lasting health. Through our partnerships, programmes and investments, we’re working to prevent disease, expand access to treatments and reduce our environmental impact to help even more people live healthier lives. For more information, visit novonordisk.com and follow us on Instagram, LinkedIn, TikTok, Facebook, X and YouTube.
Contacts for further information
| Novo Nordisk Media: | |
| Ambre James-Brown +45 3079 9289 globalmedia@novonordisk.com | Liz Skrbkova (US) +1 609 917 0632 USMediaRelations@novonordisk.com |
| Novo Nordisk Investors: | |
| Michael Novod +45 3075 6050 nvno@novonordisk.com | Sina Meyer +45 3079 6656 azey@novonordisk.com |
| Christoffer Togo Solgaard-Tullin +45 3079 1471 cftu@novonordisk.com | |
| Ida Schaap Melvold +45 3077 5649 idmg@novonordisk.com | Mads Berner Bruun +45 3075 2936 mbbz@novonordisk.com |
| Frederik Taylor Pitter (US) +1 609 613 0568 fptr@novonordisk.com | Alex Bruce (US) +1 640 230 0276 axeu@novonordisk.com |
_______________________
References
- Feeding Profit: How food environments are failing children - 2025 Child Nutrition Report - UNICEF DATA - last accessed September 2026
Attachment
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Which countries are included in the expanded Novo Nordisk–UNICEF childhood obesity programme?
The expanded programme will support action in Mexico, Colombia, Indonesia, the Philippines, India, Egypt and Kenya, with learning accelerated across regions.
When does the funding and the four-year programme period take place?
Novo Nordisk will provide USD 18 million from 2026 to 2030. Funding begins in 2026 to support programme inception and preparation, and the four-year programme itself will run from 2027 to 2030.
What kinds of interventions will the partnership support to prevent childhood overweight and obesity?
The programme will support growth monitoring, nutrition and physical activity counselling, peer and family support, community- and facility-based prevention activities, youth advocacy, basic mental health screening and support, and legislation to promote better diets and healthy food.
How will success of the expanded partnership be measured and reported?
Success will be measured by the number of children reached by evidence-based prevention policies and interventions. Progress and challenges will be reported transparently, in the company’s description.
What delivery model will UNICEF use for this expanded programme?
Delivery will be country-led and anchored in UNICEF’s Centres of Excellence model, led from Nairobi with satellite support in Bangkok and Panama.